Kurach J, Brandon-Coatham M, Olafson C, Turner T, Phan C, Yazdanbakhsh M
Transfusion. 2024; 64(12):2353-2363.
PMID: 39485279
PMC: 11637290.
DOI: 10.1111/trf.18054.
Ebenuwa I, Violet P, Tu H, Lee C, Munyan N, Wang Y
Cardiovasc Diabetol. 2024; 23(1):370.
PMID: 39425096
PMC: 11490132.
DOI: 10.1186/s12933-024-02453-2.
Boning D, Bloch W, Vogel D, Steinach M, Kuebler W
Front Physiol. 2024; 15:1426505.
PMID: 39318367
PMC: 11420525.
DOI: 10.3389/fphys.2024.1426505.
Kassa T, Jana S, Baek J, Alayash A
Front Physiol. 2024; 15:1427094.
PMID: 39224206
PMC: 11366621.
DOI: 10.3389/fphys.2024.1427094.
Glenthoj A, Rasmussen A, Bendtsen S, Hasle H, Hoffmann M, Rieneck K
Orphanet J Rare Dis. 2024; 19(1):284.
PMID: 39085840
PMC: 11290079.
DOI: 10.1186/s13023-024-03298-4.
Rapid measurement of hemoglobin-oxygen dissociation by leveraging Bohr effect and Soret band bathochromic shift.
Sekyonda Z, An R, Goreke U, Man Y, Monchamp K, Bode A
Analyst. 2024; 149(9):2561-2572.
PMID: 38501195
PMC: 11056771.
DOI: 10.1039/d3an02071a.
Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE-KIDS 1 trial.
Chonat S, Fields E, Baratz H, Watt A, Pochron M, Dixon S
EJHaem. 2024; 5(1):125-130.
PMID: 38406531
PMC: 10887232.
DOI: 10.1002/jha2.831.
COVID-19 impairs oxygen delivery by altering red blood cell hematological, hemorheological, and oxygen transport properties.
Rogers S, Brummet M, Safari Z, Wang Q, Rowden T, Boyer T
Front Physiol. 2024; 14:1320697.
PMID: 38235386
PMC: 10791868.
DOI: 10.3389/fphys.2023.1320697.
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study.
van Dijk M, Rab M, van Oirschot B, Bos J, Derichs C, Rijneveld A
Blood Adv. 2023; 7(24):7539-7550.
PMID: 37934880
PMC: 10761354.
DOI: 10.1182/bloodadvances.2023011477.
On the Origin of Hemoglobin Cooperativity under Non-equilibrium Conditions.
Scrima R, Fugetto S, Capitanio N, Gatti D
Discoveries (Craiova). 2023; 10(2):e146.
PMID: 37593464
PMC: 10431948.
DOI: 10.15190/d.2022.5.
The oxygen dissociation curve of blood in COVID-19-An update.
Boning D, Kuebler W, Vogel D, Bloch W
Front Med (Lausanne). 2023; 10:1098547.
PMID: 36923010
PMC: 10008909.
DOI: 10.3389/fmed.2023.1098547.
Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review.
van Dijk M, van Oirschot B, Stam-Slob M, Waanders E, Van der Zwaag B, van Beers E
Br J Haematol. 2022; 200(2):249-255.
PMID: 36177683
PMC: 10092417.
DOI: 10.1111/bjh.18485.
Safety, Pharmacokinetics, and Pharmacodynamics of Etavopivat (FT-4202), an Allosteric Activator of Pyruvate Kinase-R, in Healthy Adults: A Randomized, Placebo-Controlled, Double-Blind, First-in-Human Phase 1 Trial.
Forsyth S, Schroeder P, Geib J, Vrishabhendra L, Konstantinidis D, LaSalvia K
Clin Pharmacol Drug Dev. 2022; 11(5):654-665.
PMID: 35019238
PMC: 9306898.
DOI: 10.1002/cpdd.1058.
The oxygen dissociation curve of blood in COVID-19.
Boning D, Kuebler W, Bloch W
Am J Physiol Lung Cell Mol Physiol. 2021; 321(2):L349-L357.
PMID: 33978488
PMC: 8384474.
DOI: 10.1152/ajplung.00079.2021.
Hydrogen Sulfide Is a Regulator of Hemoglobin Oxygen-Carrying Capacity via Controlling 2,3-BPG Production in Erythrocytes.
Wang G, Huang Y, Zhang N, Liu W, Wang C, Zhu X
Oxid Med Cell Longev. 2021; 2021:8877691.
PMID: 33628390
PMC: 7896853.
DOI: 10.1155/2021/8877691.
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.
Farrell A, Panepinto J, Desai A, Kassim A, Lebensburger J, Walters M
Blood Adv. 2019; 3(23):4002-4020.
PMID: 31809537
PMC: 6963248.
DOI: 10.1182/bloodadvances.2019000883.
Genetic programming of macrophages generates an in vitro model for the human erythroid island niche.
Lopez-Yrigoyen M, Yang C, Fidanza A, Cassetta L, Taylor A, McCahill A
Nat Commun. 2019; 10(1):881.
PMID: 30787325
PMC: 6382809.
DOI: 10.1038/s41467-019-08705-0.
GBT440 reverses sickling of sickled red blood cells under hypoxic conditions .
Dufu K, Oksenberg D
Hematol Rep. 2018; 10(2):7419.
PMID: 30046411
PMC: 6036981.
DOI: 10.4081/hr.2018.7419.
Development and validation of an oxygen dissociation assay, a screening platform for discovering, and characterizing hemoglobin-oxygen affinity modifiers.
Patel M, Siu V, Silva-Garcia A, Xu Q, Li Z, Oksenberg D
Drug Des Devel Ther. 2018; 12:1599-1607.
PMID: 29910606
PMC: 5989706.
DOI: 10.2147/DDDT.S157570.
Chemical Transport Knockout for Oxidized Vitamin C, Dehydroascorbic Acid, Reveals Its Functions in vivo.
Tu H, Wang Y, Li H, Brinster L, Levine M
EBioMedicine. 2017; 23:125-135.
PMID: 28851583
PMC: 5605377.
DOI: 10.1016/j.ebiom.2017.08.017.